The novel tubulin-binding drug BTO-956 inhibits R3230Ac mammary carcinoma growth and angiogenesis in fischer 344 rats

Clinical Cancer Research

Volumn 7, Issue 8, 2001, Pages 2590-2596

  Shah, Siqing ^a   Lockhart, A Craig ^a   Saito, Wilfred Y ^a   Knapp, A Merrill ^b   Laderoute, Keith R ^b   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BTO 956; METHYL 3,5 DIIODO 4 (4' METHOXYPHENOXY)BENZOATE; RECOMBINANT FIBROBLAST GROWTH FACTOR; SUCRALFATE; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG STRUCTURE; FEMALE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; CORNEAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IODOBENZOATES; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; RATS; RATS, INBRED F344; TUBULIN;

EID: 0034892665     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Clinical application of research on angiogenesis. Seminars in Medicine of the Beth Israel Hospital, Boston
2. The rationale and future potential of angiogenesis inhibitors in neoplasia
3. Chemotherapy targeted to tumor vasculature
4. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process
5. Promising new developments in cancer chemotherapy
6. The action of toxic substances upon the division of normal and malignant cells in vitro and in vivo
7. Colchicine in the experimental chemotherapy of cancer
8. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
9. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumor perfusion and energetic status
10. Antigoitrogenic and calorigenic activities of thyroxine analogues in rats
11. Induction of tumor apoptosis by methyl-3, 5-diiodo-4-(4′-methoxyphenoxy)benzoate (DIME)
12. Oncocidin A1: A novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice
13. Assay and purification of naturally occurring inhibitor of angiogenesis
14. A transparent access chamber for the rat dorsal skin fold
15. Tumor induction of VEGF promoter activity in stromal cells
16. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models
17. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4
18. Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy
19. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor
20. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
21. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
22. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
23. Tissue response to tumor invasion and inhibits tumor growth
24. Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice
25. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice
26. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma